Mercury Laboratories Ltd
Mercury Laboratories (BSE)

501.90

60.23
Proj. ROE (%)
-
Proj. P/E (x)
-
Proj EV / EBITDA (x)
-
Proj. P/BV (x)
-
Proj. Revenue ( Cr.)
-

Stock View

-
Share on
The average score for Mercury Laboratories Ltd stands at 7 against 5, three months back.

Mercury Laboratories Limited is an India-based pharmaceutical company. The Company is engaged in the manufacturing of pharmaceuticals, medicinal drugs and formulations. The Company’s products include Analgesic, Anti-inflammatory, Anti-pyretic, Anthelmintic, Antibiotic, Anti-coagulant, Anti- platelet, Bleeding agents, Anti-fungal, Anti-hypertensive drugs, Anti-malarial drugs, Cardiovascular System, Central Nervous System, Eye, Gastro-intestinal system, Hypoglycemic (Anti-diabetic), Multivitamin, Protein supplement, Respiratory System, Anti- allergic, Steroids, Urinary system, Uterine stimulant and Miscellaneous. Its products also include Gynec, Paediatric, Surgeon, Physician, Antihypertensive (PIH), PCOS & Uterine Disorders, Galactagogue, Haemostat, Iron and Vitamins, Preterm Labor Management, Antiemetic, Dexamethasone Tablet, Glucosamine Sulphate, Prednisolone Acetate Ophthalmic Suspension USP, Ketorolac Tromethamine 0.4% Eye Drops and Ketorolac Tromethamine 0.4% Eye Drops.

Disclaimer : All estimates (1 year forward) are based on Consensus View provided by Refinitiv.

Technical Data
50 DMA()
483.63
100 DMA ()
520.88
200 DMA ()
598.73
52 Weeks Range
390.00
813.00
Street View :-
Bearish
Open ZERO Brokerage Demat Account
Open Demat Account

  • 0

    Per Order for ETF & Mutual Funds Brokerage

  • 20

    Per Order for Delivery, Intraday, F&O, Currency & Commodity